|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02096 SIMCERE PHARMA
Nominal 
12.400 +0.380 (+3.161%) Ranking Overview
Ranking based on 4 research report(s)
Average Ranking 2.25
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 29.00 RMB (cts) | |
| Net Profit | 733.17 RMB (MIL) | DPS | 16.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,247.50 | 49.00 | 24.50 | -- | 1,276.00 | 1,153.00 |
| 2026 | 1,542.00 | 61.00 | 29.67 | -- | 2,834.00 | 1,376.00 |
| 2027 | 1,695.50 | 65.50 | 33.19 | -- | 1,967.00 | 1,568.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,153.00 | 44.00 | 22.00 | SINOLINK SEC | Buy | 20.16 | 26/12/2025 | |
| 2025 | 1,244.00 | 48.00 | 27.26 | HUATAI FIN HLDGS HK | Buy | 19.82 | 04/02/2026 | |
| 2025 | 1,251.00 | 51.00 | 27.00 | UBS | Buy | 16.30 | 25/02/2026 | |
| 2025 | 1,276.00 | 50.00 | -- | MORGAN STANLEY | Equal-weight | 12.30 | 09/01/2026 | |
| 2026 | 1,376.00 | 53.00 | 27.00 | SINOLINK SEC | - | -- | 26/12/2025 | |
| 2026 | 1,476.00 | 57.00 | 32.34 | HUATAI FIN HLDGS HK | - | -- | 04/02/2026 | |
| 2026 | 1,608.00 | 65.00 | 35.00 | UBS | - | -- | 25/02/2026 | |
| 2026 | 2,834.00 | 108.00 | -- | MORGAN STANLEY | - | -- | 09/01/2026 | |
| 2027 | 1,658.00 | 64.00 | 32.00 | SINOLINK SEC | - | -- | 26/12/2025 | |
| 2027 | 1,568.00 | 60.00 | 34.38 | HUATAI FIN HLDGS HK | - | -- | 04/02/2026 | |
| 2027 | 1,967.00 | 79.00 | 43.00 | UBS | - | -- | 25/02/2026 | |
| 2027 | 1,733.00 | 67.00 | -- | MORGAN STANLEY | - | -- | 09/01/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 27/02/2026 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 603,607 |
| %Change | 32.196% |
| EPS / (LPS) | RMB 0.250 |
| NBV Per Share (¥) | RMB 2.923 |